Both in Pharmaceuticals
Generate Biomedicines vs Nurix Therapeutics
Over the past year GENB returned −9.9% and NRIX returned −36.5%; their daily moves had a correlation of 0.09.
GENB −9.9% NRIX −36.5%Growth of $1, one year, split-adjusted
| Metric | GENB | NRIX |
|---|---|---|
| Price | $14.16 | $15.95 |
| Market cap | $1.82B | $1.74B |
| Today | +2.24% | −38.23% |
| 1 month | +2.6% | −29.4% |
| 6 months | — | −5.5% |
| Year to date | — | −15.9% |
| 1 year | — | +26.4% |
| Revenue growth (YoY) | — | +8426.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1065.2% | 81.7% |
| P/E (TTM) | — | 5.9× |
| Price / sales | — | 2.5× |
| Net cash | $452.3M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | — | 104.6% |
| Short % of float | 15.4% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).